when were glp 1 agonists approved GLP-1R for Weight Loss Evolution of GLP‐1 Receptor Agonists
Description
All that follows is from the above resource

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.
GLP-1 receptor agonists are medications used to manage obesity and type 2 diabetes

This is a huge market

Alabamas attorney general recently filed a lawsuit against a medical spa alleging that it administered unapproved versions of GLP-1 weight loss drugs to patients without informing them that the formulations were not authorized by the FDA

China is Next Big Market: Manufacturing Challenges, Supply Shortages